Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 50,917 | 38,093 | 33,432 | 25,115 | 41,463 |
| Gross Profit | 50,917 | 38,093 | 33,432 | 25,115 | 41,463 |
| Operating Expenses | 28,296 | 20,414 | 29,321 | 33,567 | 29,806 |
| Operating Income | 22,621 | 17,679 | 4,111 | -8,452 | 11,657 |
| Other Income | 966 | 1,260 | 1,686 | 1,969 | 2,183 |
| Pre-tax Income | 23,587 | 18,939 | 5,797 | -6,483 | 13,840 |
| Income Tax | 62 | 63 | 61 | 51 | 49 |
| Net Income Continuous | 23,525 | 18,876 | 5,736 | -6,534 | 13,791 |
| Net Income | $23,525 | $18,876 | $5,736 | $-6,534 | $13,791 |
| EPS Basic Total Ops | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 |
| EPS Basic Continuous Ops | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 |
| EPS Diluted Total Ops | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 |
| EPS Diluted Continuous Ops | 0.27 | 0.22 | 0.07 | -0.08 | 0.17 |
| EPS Diluted Before Non-Recurring Items | 0.27 | 0.22 | 0.07 | N/A | N/A |
| EBITDA(a) | $22,552 | $17,305 | $3,320 | $-9,431 | $10,258 |